|
1.
|
Lee S, Gang J, Jeon SB, et al: Molecular
cloning and functional analysis of a novel oncogene,
cancer-upregulated gene 2 (CUG2). Biochem Biophys Res Commun.
360:633–639. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Kim H, Lee M, Lee S, et al:
Cancer-upregulated gene 2 (CUG2), a new component of centromere
complex, is required for kinetochore function. Mol Cells.
27:697–701. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Park EH, Park EH, Cho IR, et al: CUG2, a
novel oncogene confers reoviral replication through Ras and p38
signaling pathway. Cancer Gene Ther. 17:307–314. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Malilas W, Koh SS, Srisuttee R, et al:
Cancer upregulated gene 2, a novel oncogene, confers resistance to
oncolytic vesicular stomatitis virus through STAT1-OASL2 signaling.
Cancer Gene Ther. 20:125–132. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Chin YE, Kitagawa M, Kuida K, Flavell RA
and Fu XY: Activation of the STAT signaling pathway can cause
expression of caspase 1 and apoptosis. Mol Cell Biol. 17:5328–5337.
1997.PubMed/NCBI
|
|
6.
|
Kumar A, Commane M, Flickinger TW, Horvath
CM and Stark GR: Defective TNF-alpha-induced apoptosis in
STAT1-null cells due to low constitutive levels of caspases.
Science. 278:1630–1632. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Chin YE, Kitagawa M, Su WC, You ZH,
Iwamoto Y and Fu XY: Cell growth arrest and induction of
cyclin-dependent kinase inhibitor p21 WAF1/CIP1 mediated by STAT1.
Science. 272:719–722. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Townsend PA, Scarabelli TM, Davidson SM,
Knight RA, Latchman DS and Stephanou A: STAT-1 interacts with p53
to enhance DNA damage-induced apoptosis. J Biol Chem.
279:5811–5820. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Stephanou A, Brar BK, Knight RA and
Latchman DS: Opposing actions of STAT-1 and STAT-3 on the Bcl-2 and
Bcl-x promoters. Cell Death Differ. 7:329–330. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Khodarev NN, Beckett M, Labay E, Darga T,
Roizman B and Weichselbaum RR: STAT1 is overexpressed in tumors
selected for radioresistance and confers protection from radiation
in transduced sensitive cells. Proc Natl Acad Sci USA.
101:1714–1719. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Fryknas M, Dhar S, Oberg F, et al: STAT1
signaling is associated with acquired crossresistance to
doxorubicin and radiation in myeloma cell lines. Int J Cancer.
120:189–195. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Roberts D, Schick J, Conway S, et al:
Identification of genes associated with platinum drug sensitivity
and resistance in human ovarian cancer cells. Br J Cancer.
92:1149–1158. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Weichselbaum RR, Ishwaran H, Yoon T, et
al: An interferon-related gene signature for DNA damage resistance
is a predictive marker for chemotherapy and radiation for breast
cancer. Proc Natl Acad Sci USA. 105:18490–18495. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Park HD, Lee Y, Oh YK, et al: Pancreatic
adenocarcinoma up regulated factor promotes metastasis by
regulating TLR/CXCR4 activation. Oncogene. 30:201–211. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Liang CC, Park AY and Guan JL: In vitro
scratch assay: a convenient and inexpensive method for analysis of
cell migration in vitro. Nat Protoc. 2:329–333. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Raven JF, Williams V, Wang S, et al: Stat1
is a suppressor of ErbB2/Neu-mediated cellular transformation and
mouse mammary gland tumor formation. Cell Cycle. 10:794–804. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Kaplan DH, Shankaran V, Dighe AS, et al:
Demonstration of an interferon gamma-dependent tumor surveillance
system in immunocompetent mice. Proc Natl Acad Sci USA.
95:7556–7561. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Wang S and Koromilas AE: Stat1 is an
inhibitor of Ras-MAPK signaling and Rho small GTPase expression
with implications in the transcriptional signature of Ras
transformed cells. Cell Cycle. 8:2070–2079. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Wang S, Raven JF, Durbin JE and Koromilas
AE: Stat1 phosphorylation determines Ras oncogenicity by regulating
p27 kip1. PLoS One. 3:e34762008. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Khodarev NN, Roach P, Pitroda SP, et al:
STAT1 pathway mediates amplification of metastatic potential and
resistance to therapy. PLoS One. 4:e58212009. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Rickardson L, Fryknas M, Dhar S, et al:
Identification of molecular mechanisms for cellular drug resistance
by combining drug activity and gene expression profiles. Br J
Cancer. 93:483–492. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Pitroda SP, Wakim BT, Sood RF, et al:
STAT1-dependent expression of energy metabolic pathways links
tumour growth and radioresistance to the Warburg effect. BMC Med.
7:682009. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Chun Y, Park B, Koh W, et al: New
centromeric component CENP-W is an RNA-associated nuclear matrix
protein that interacts with nucleophosmin/B23 protein. J Biol Chem.
286:42758–42769. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Okuwaki M: The structure and functions of
NPM1/Nucleophsmin/B23, a multifunctional nucleolar acidic protein.
J Biochem. 143:441–448. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Grisendi S, Mecucci C, Falini B and
Pandolfi PP: Nucleophosmin and cancer. Nat Rev Cancer. 6:493–505.
2006. View
Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Khodarev NN, Roizman B and Weichselbaum
RR: Molecular pathways: interferon/stat1 pathway: role in the tumor
resistance to genotoxic stress and aggressive growth. Clin Cancer
Res. 18:3015–3021. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Velasco-Velazquez M, Jiao X, De La Fuente
M, et al: CCR5 antagonist blocks metastasis of basal breast cancer
cells. Cancer Res. 72:3839–3850. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Kitamura T, Fujishita T, Loetscher P, et
al: Inactivation of chemokine (C-C motif) receptor 1 (CCR1)
suppresses colon cancer liver metastasis by blocking accumulation
of immature myeloid cells in a mouse model. Proc Natl Acad Sci USA.
107:13063–13068. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Lee JH, Kim HN, Kim KO, et al: CXCL10
promotes osteolytic bone metastasis by enhancing cancer outgrowth
and osteoclasto-genesis. Cancer Res. 72:3175–3186. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Nakano M, Fujii T, Hashimoto M, et al:
Type I interferon induces CX3CL1 (fractalkine) and CCL5 (RANTES)
production in human pulmonary vascular endothelial cells. Clin Exp
Immunol. 170:94–100. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Nardi V, Naveiras O, Azam M and Daley GQ:
ICSBP-mediated immune protection against BCR-ABL-induced leukemia
requires the CCL6 and CCL9 chemokines. Blood. 113:3813–3820. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Ohmori Y and Hamilton TA: Cooperative
interaction between interferon (IFN) stimulus response element and
kappaB sequence motifs controls IFN gamma- and
lipopolysaccharide-stimulated transcription from the murine IP-10
promoter. J Biol Chem. 268:6677–6688. 1993.
|
